Your browser doesn't support javascript.
loading
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
Camacho, Niedzica; Van Loo, Peter; Edwards, Sandra; Kay, Jonathan D; Matthews, Lucy; Haase, Kerstin; Clark, Jeremy; Dennis, Nening; Thomas, Sarah; Kremeyer, Barbara; Zamora, Jorge; Butler, Adam P; Gundem, Gunes; Merson, Sue; Luxton, Hayley; Hawkins, Steve; Ghori, Mohammed; Marsden, Luke; Lambert, Adam; Karaszi, Katalin; Pelvender, Gill; Massie, Charlie E; Kote-Jarai, Zsofia; Raine, Keiran; Jones, David; Howat, William J; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Nicol, David; Mayer, Erik; Dudderidge, Tim; Yu, Yongwei; Zhang, Hongwei; Shah, Nimish C; Gnanapragasam, Vincent J; Isaacs, William; Visakorpi, Tapio; Hamdy, Freddie; Berney, Dan; Verrill, Clare; Warren, Anne Y; Wedge, David C; Lynch, Andrew G; Foster, Christopher S; Lu, Yong Jie; Bova, G Steven.
Afiliação
  • Camacho N; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
  • Van Loo P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Edwards S; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Kay JD; Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Matthews L; Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Haase K; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
  • Clark J; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
  • Dennis N; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom.
  • Thomas S; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
  • Kremeyer B; Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Zamora J; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
  • Butler AP; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Gundem G; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Merson S; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Luxton H; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Hawkins S; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Ghori M; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Marsden L; Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
  • Lambert A; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
  • Karaszi K; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
  • Pelvender G; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom.
  • Massie CE; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
  • Kote-Jarai Z; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Raine K; Department of Physiology, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Jones D; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, Oxfordshire, United Kingdom.
  • Howat WJ; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, Oxfordshire, United Kingdom.
  • Hazell S; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Livni N; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Fisher C; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
  • Ogden C; CRUK Cambridge Centre, Early Detection Programme, Urological Malignancies Programme, Hutchison-MRC Research Centre, Cambridge, Cambridgeshire, United Kingdom.
  • Kumar P; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
  • Thompson A; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Nicol D; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
  • Mayer E; Histopathology and in situ hybridization Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
  • Dudderidge T; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Yu Y; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Zhang H; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Shah NC; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Gnanapragasam VJ; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Isaacs W; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Visakorpi T; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Hamdy F; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Berney D; Department of Epidemiology, Second Military Medical University, Shanghai, China.
  • Verrill C; Department of Epidemiology, Second Military Medical University, Shanghai, China.
  • Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom.
  • Wedge DC; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.
  • Foster CS; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Lu YJ; Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere and Tampere University Hospital, Tampere, Finland.
  • Bova GS; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
PLoS Genet ; 13(9): e1007001, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28945760
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Análise de Sequência de DNA / Variações do Número de Cópias de DNA / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Análise de Sequência de DNA / Variações do Número de Cópias de DNA / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido